Drug details

Krystexxa (pegloticase injection)

type of Rheumatologics, Other, Enzymes, Oncology

Krystexxa (pegloticase) Injection for Intravenous Infusion is an enzyme that metabolizes uric acid into a harmless chemical that is eliminated from the body in urine and is used to treat chronic gout. Krystexxa is usually given after other gout medications have been tried without successful treatment of symptoms.

The drug is often used to treat Gout .

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• wheezing,
• chest pain, and
• flushing (warmth, redness, or tingly feeling)

The following drugs are related to Krystexxa, either as a replacement or used together:

• Zyloprim (allopurinol)
• Anturane (sulfinpyrazone)
• Cataflam (diclofenac potassium immediate-release tablets)
• Clinoril (sulindac)
• Gloperba (colchicine oral solution)
• ColciGel (colchicinum 4x transdermal gel)
• Cytra-K (potassium citrate and citric acid granules)
• Voltaren (diclofenac sodium)
• Voltaren XR (diclofenac sodium extended-release tablets)
• Voltaren Gel (diclofenac sodium gel)
• Uloric (febuxostat)
• Medrol (methylprednisolone)
• Naprosyn, Anaprox, Anaprox DS (naproxen)
• Urocit-K (potassium citrate extended-release tablets)